Amgen Ltd

240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)808 0100 321
Medical Information Fax: +44 (0)1223 426 314
Patient Information Leaflet last updated on the eMC: 12/10/2009
PIL Mimpara

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/07/2008 and displayed until 12/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 06/11/2007 and displayed until 09/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 27/04/2006 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 21/03/2006 and displayed until 27/04/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/11/2004 and displayed until 21/03/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   cinacalcet hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk